0000950170-24-014919.txt : 20240214 0000950170-24-014919.hdr.sgml : 20240214 20240214060609 ACCESSION NUMBER: 0000950170-24-014919 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20240213 ITEM INFORMATION: Termination of a Material Definitive Agreement FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Larimar Therapeutics, Inc. CENTRAL INDEX KEY: 0001374690 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 203857670 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36510 FILM NUMBER: 24631865 BUSINESS ADDRESS: STREET 1: THREE BALA PLAZA EAST. SUITE 506 CITY: BALA CYNWYD STATE: PA ZIP: 19004 BUSINESS PHONE: 844-511-9056 MAIL ADDRESS: STREET 1: THREE BALA PLAZA EAST. SUITE 506 CITY: BALA CYNWYD STATE: PA ZIP: 19004 FORMER COMPANY: FORMER CONFORMED NAME: ZAFGEN, INC. DATE OF NAME CHANGE: 20100301 FORMER COMPANY: FORMER CONFORMED NAME: ZAFGEN INC DATE OF NAME CHANGE: 20060906 8-K 1 lrmr-20240213.htm 8-K 8-K
false000137469000013746902024-02-132024-02-13

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 13, 2024

 

 

Larimar Therapeutics, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-36510

20-3857670

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

Three Bala Plaza East

 

Bala Cynwyd, Pennsylvania

 

19004

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (844) 511-9056

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $0.001 per share

 

LRMR

 

Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Item 1.02 Termination of a Material Definitive Agreement.

On February 13, 2024, Larimar Therapeutics, Inc. (the “Company”) gave notice to terminate the Sales Agreement that the Company entered into with Guggenheim Securities, LLC on November 10, 2022 (the “Sales Agreement”). Termination of the Sales Agreement was effective February 13, 2024. Under the Sales Agreement, the Company was permitted to offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.001 per share (“Common Stock”), having an aggregate offering price of up to $50,000,000 through Guggenheim as its sales agent by any method permitted by law deemed to be an “at the market offering” as defined in Rule 415 of the Securities Act of 1933, as amended. During the term of the Sales Agreement, the Company had not sold any shares of its Common Stock thereunder.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Larimar Therapeutics, Inc.

 

 

 

 

Date:

February 14, 2024

By:

/s/ Carole S. Ben-Maimon, M.D.

 

 

 

Name: Carole S. Ben-Maimon, M.D.
Title: President and Chief Executive Officer

 

 EX-101.SCH 2 lrmr-20240213.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications XML 3 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document And Entity Information
Feb. 13, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Feb. 13, 2024
Entity Registrant Name Larimar Therapeutics, Inc.
Entity Central Index Key 0001374690
Entity Emerging Growth Company false
Entity File Number 001-36510
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 20-3857670
Entity Address, Address Line One Three Bala Plaza East
Entity Address, City or Town Bala Cynwyd
Entity Address, State or Province PA
Entity Address, Postal Zip Code 19004
City Area Code (844)
Local Phone Number 511-9056
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol LRMR
Security Exchange Name NASDAQ
EXCEL 5 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 6 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 7 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports lrmr-20240213.htm lrmr-20240213.xsd http://xbrl.sec.gov/dei/2023 false false JSON 11 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "lrmr-20240213.htm": { "nsprefix": "lrmr", "nsuri": "http://www.larimartx.com/20240213", "dts": { "inline": { "local": [ "lrmr-20240213.htm" ] }, "schema": { "local": [ "lrmr-20240213.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_76ae29ff-a887-48f6-b546-9e2245f65561", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "lrmr-20240213.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76ae29ff-a887-48f6-b546-9e2245f65561", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "lrmr-20240213.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.larimartx.com/20240213/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 12 0000950170-24-014919-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-014919-xbrl.zip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lrmr-20240213_htm.xml IDEA: XBRL DOCUMENT 0001374690 2024-02-13 2024-02-13 false 0001374690 8-K 2024-02-13 Larimar Therapeutics, Inc. DE 001-36510 20-3857670 Three Bala Plaza East Bala Cynwyd PA 19004 (844) 511-9056 false false false false Common Stock, par value $0.001 per share LRMR NASDAQ false